A Phase 1/1b study of ProAgio in advanced/metastatic colorectal cancer
Recruiting Phase 1 NCT06867822
Study Description
A clinical trial to evaluate the safety and effectiveness of ProAgio in combination with standard chemotherapy and targeted therapy for advanced or metastatic colorectal cancer
Study Details
- Registry ID:
- NCT06867822
- Conditions:
- Advanced Colorectal Cancer, Metastatic Colorectal Cancer
- Phase:
- Phase 1
- Target Enrollment:
- 27 participants
- Start Date:
- Age Range:
- 19–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
University of Alabama at Birmingham
Birmingham, Alabama, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.